Avantor, Inc. Amortization
Avantor, Inc. (AVTR) reported Amortization of $75.70 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2026-04-29
- Avantor, Inc. amortization for the quarter ending 2026-03-31 was $75.70M, a 2.44% increase year-over-year.
- Avantor, Inc. amortization for the quarter ending 2025-12-31 was $75.60M, a 1.89% increase year-over-year.
- Avantor, Inc. amortization for the quarter ending 2025-09-30 was $76.10M, a 0.93% increase year-over-year.
- Avantor, Inc. amortization for the quarter ending 2025-06-30 was $75.50M, a 0.80% increase year-over-year.
- Avantor, Inc. amortization for fiscal 2025 was $301.10M, a 0.43% increase from fiscal 2024.
- Avantor, Inc. amortization for fiscal 2024 was $299.80M, a 2.57% decline from fiscal 2023.
- Avantor, Inc. amortization for fiscal 2023 was $307.70M, a 3.33% decline from fiscal 2022.
- Avantor, Inc. amortization for fiscal 2022 was $318.30M.
| Period end | Amortization 3 month | Amortization 6 month | Amortization 9 month | Amortization 12 month |
|---|---|---|---|---|
| 2026-03-31 | $75.70M 10-Q · filed 2026-04-29 | $151.30M derived: sum of 2 quarters · filed 2026-04-29 | $227.40M derived: sum of 3 quarters · filed 2026-04-29 | $302.90M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $75.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $151.70M derived: sum of 2 quarters · filed 2026-02-11 | $227.20M derived: sum of 3 quarters · filed 2026-02-11 | $301.10M 10-K · filed 2026-02-11 |
| 2025-09-30 | $76.10M 10-Q · filed 2025-10-29 | $151.60M derived: sum of 2 quarters · filed 2025-10-29 | $225.50M 10-Q · filed 2025-10-29 | $299.70M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | $75.50M 10-Q · filed 2025-08-01 | $149.40M 10-Q · filed 2025-08-01 | $223.60M derived: sum of 3 quarters · filed 2026-04-29 | $299.00M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | $73.90M 10-Q · filed 2026-04-29 | $148.10M derived: sum of 2 quarters · filed 2026-04-29 | $223.50M derived: sum of 3 quarters · filed 2026-04-29 | $298.40M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $74.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $149.60M derived: sum of 2 quarters · filed 2026-02-11 | $224.50M derived: sum of 3 quarters · filed 2026-02-11 | $299.80M 10-K · filed 2026-02-11 |
| 2024-09-30 | $75.40M 10-Q · filed 2025-10-29 | $150.30M derived: sum of 2 quarters · filed 2025-10-29 | $225.60M 10-Q · filed 2025-10-29 | $300.60M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $74.90M 10-Q · filed 2025-08-01 | $150.20M 10-Q · filed 2025-08-01 | $225.20M derived: sum of 3 quarters · filed 2026-02-11 | $300.60M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $75.30M 10-Q · filed 2025-04-25 | $150.30M derived: sum of 2 quarters · filed 2026-02-11 | $225.70M derived: sum of 3 quarters · filed 2026-02-11 | $304.60M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $75.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $150.40M derived: sum of 2 quarters · filed 2026-02-11 | $229.30M derived: sum of 3 quarters · filed 2026-02-11 | $307.70M 10-K · filed 2026-02-11 |
| 2023-09-30 | $75.40M 10-Q · filed 2024-10-25 | $154.30M derived: sum of 2 quarters · filed 2024-10-25 | $232.70M 10-Q · filed 2024-10-25 | |
| 2023-06-30 | $78.90M 10-Q · filed 2024-07-26 | $157.30M 10-Q · filed 2024-07-26 | ||
| 2023-03-31 | $78.40M 10-Q · filed 2024-04-26 | |||
| 2022-12-31 | $318.30M 10-K · filed 2025-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |